It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The small intestinal mucosa-associated microbiota (MAM) can potentially impact the etiology of primary biliary cholangitis (PBC). Herein, we investigate the MAM profile to determine its association with liver pathology in patients with PBC. Thirty-four patients with PBC and 21 healthy controls who underwent colonoscopy at our hospital were enrolled in our study. We performed 16S ribosomal RNA gene sequencing of MAM samples obtained from the mucosa of the terminal ileum and examined the relationship between the abundance of ileal MAM and chronic nonsuppurative destructive cholangitis using liver specimens from patients with PBC. There was a significant reduction in microbial diversity within individuals with PBC (P = 0.039). Dysbiosis of ileal MAM was observed in patients with PBC, with a characteristic overgrowth of Sphingomonadaceae and Pseudomonas. Multivariate analysis showed that the overgrowth of Sphingomonadaceae and Pseudomonas is an independent association factor for PBC (P = 0.0429, P = 0.026). Moreover, the abundance of Sphingomonadaceae was associated with chronic nonsuppurative destructive cholangitis in PBC (P = 0.00981). The overgrowth of Sphingomonadaceae and Pseudomonas in ileal MAM was found in patients with PBC. Sphingomonadaceae may be associated with the pathological development of PBC.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Ehime University Graduate School of Medicine, Department of Gastroenterology and Metabology, Ehime, Japan (GRID:grid.255464.4) (ISNI:0000 0001 1011 3808)
2 Ehime University Graduate School of Medicine, Endoscopy Center, Ehime, Japan (GRID:grid.255464.4) (ISNI:0000 0001 1011 3808)
3 Ehime University Graduate School of Medicine, Department of Community Medicine, Ehime, Japan (GRID:grid.255464.4) (ISNI:0000 0001 1011 3808)
4 Ehime University, Health Services Center, Ehime, Japan (GRID:grid.255464.4) (ISNI:0000 0001 1011 3808)
5 Ehime University Hospital Postgraduate Medical Education Center, Ehime, Japan (GRID:grid.452478.8) (ISNI:0000 0004 0621 7227)
6 Ehime University Graduate School of Medicine, Department of Inflammatory Bowel Diseases and Therapeutics, Ehime, Japan (GRID:grid.255464.4) (ISNI:0000 0001 1011 3808)